Literature search and pre-formulation studies
Formulation Research & Development drives pharmaceutical innovation by transforming scientific discoveries into life-saving treatments for patients. Our approach is centred on developing safe, stable, and effective dosage forms that ensure optimal drug delivery and patient convenience.
At the core of Hab Pharma’s R&D lies the objective to convert active pharmaceutical ingredients into formulations that remain physically and chemically viable throughout their shelf life, while maintaining ease of administration and consistent therapeutic performance.
Our multidisciplinary R&D framework encompasses:
Development of robust formulations and seamless transfer to manufacturing.
Establishment and validation of analytical methods to ensure product quality.
Ensuring adherence to quality standards across all development stages.
Supporting innovation through structured IP strategies.
Aligning development with regulatory requirements for successful approvals.
Coordinating cross-functional activities for timely and efficient execution.
We also keep a detailed eye and check if there have been any neglected interactions in between the process of manufacturing to the final delivery of the goods ensuring double safety and high-quality measures.
If a cosmetic enclosure is used, tests are undertaken to check if there is any of a mixture turn adsorbed upon plastic and if any plasticizers, lubricants, pigments or stabilizers leach out of a cosmetic into a preparation.
We make sure to check and test the quality of the adhesives for an enclosure tag as a part of our quality parameters.
Our Process
Literature search and pre-formulation studies
Excipient compatibility studies
Formulation development
Optimization studies
Analytical method validation
Stability studies
Technology transfer to manufacturing
Commercialization of the product
Our R&D capabilities span a wide range of dosage forms, enabling us to address diverse therapeutic and delivery requirements across product categories.
In addition to conventional dosage forms, we possess capabilities in the development of complex and specialized formulations, supporting differentiated and high-value product development. This combination of broad formulation capabilities and advanced expertise enables the development of robust, scalable, and commercially viable pharmaceutical products.
Our R&D operations are supported by a multidisciplinary team of 43 professionals, spanning formulation development, analytical development, quality, regulatory, IP, and project management, with formulation specialists bringing up to 22 years of industry experience.
Every stage of the pipeline above is guided by Quality by Design (QbD) principles. Rather than testing quality into a product after the fact, we build it in from the start combining active ingredients with suitable excipients through structured lab-scale trials, so that each formulation is optimized, reproducible, and ready for manufacturing before it ever leaves R&D. This approach ensures consistency, process control, and a smooth transition from prototype to commercial-scale production.